The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.
To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.
For additional information please review our Privacy Policy.
Annual Meeting Gastrointestinal Press Conference - May 30, 2009 9:00 AM
Studies Answer Key Questions About Treatment of Gastronintestinal Cancers
Orlando, Fl.—The findings from several large clinical trials of new treatment regimens for gastrointestinal cancers were released Saturday, May 30, 2009 at a press briefing at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO).
“The studies presented today answer many important questions about the best care for people with gastrointestinal cancers,” said Nicholas Petrelli, MD, medical director of the Helen F. Graham Cancer Center in Wilmington, Delaware, and moderator of the press briefing. “These large, conclusive trials tell us what works, and importantly, tell us what doesn’t work. Some settle long-time debates in the field, others demonstrate that the current standard of care is actually superior to experimental treatments, and others will allow patients to avoid unnecessary side effects or surgery.
